Concepedia

Fiona McPhee

FM

Statistics

Publications

95

Citations

9.2K

H-Index

41

Active since

1991

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Inserm

The University of Texas at San Antonio Health Science Center

University of Colorado Denver

Fiona McPhee is an author at Bristol-Myers Squibb (United States) specializing in antiviral therapy, viral hepatitis, and virology.

Publications per year

1991–2021

95

Publications

95

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

Mark Sulkowski, David Gardiner, M. Rodríguez‐Torres et al. · New England Journal of Medicine · 2014 · 1.2K citations

, , +13

All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study

David R. Nelson, James N. Cooper, Jacob Lalezari et al. · Hepatology · 2015 · 689 citations · Full text

, , +15

Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1

Anna S. Lok, David Gardiner, Eric Lawitz et al. · New England Journal of Medicine · 2012 · 609 citations · Full text

, , +16

Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection

Hiromitsu Kumada, Yoshiyuki Suzuki, Kenji Ikeda et al. · Hepatology · 2014 · 539 citations · Full text

, , +17

Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence

Fred Poordad, Eugene R. Schiff, John M. Vierling et al. · Hepatology · 2016 · 459 citations · Full text

, , +17

1–5 of 95